Ming Ta Michael Lee
- Pharmacology top 2%
- Pharmacology
- Cardiology and Cardiovascular Medicine
- Pediatrics, Perinatology and Child Health
- Molecular Biology
- Co-authors
- Teri E. KleinAndrea GaedigkMichelle Whirl‐CarrilloJason H. KarnesAlison E. FohnerRachel HuddartElizabeth J. PhillipsJohn T. Callaghan
- Topics
- Pharmacogenetics and Drug Metabolism (8 papers)Health Systems, Economic Evaluations, Quality of Life (3 papers)Drug-Induced Adverse Reactions (3 papers)
- Cited by
- PharmacologyInternal Medicine
- Partner nations
- United StatesJapanTaiwan
In The Last Decade
Ming Ta Michael Lee
16 papers receiving 449 citations
Peers
Comparison fields: 5 of 77
- Pharmacology 246
- Pharmacology 87
- Cardiology and Cardiovascular Medicine 78
- Pediatrics, Perinatology and Child Health 75
- Molecular Biology 62
Countries citing papers authored by Ming Ta Michael Lee
This map shows the geographic impact of Ming Ta Michael Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Ta Michael Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Ta Michael Lee more than expected).
Fields of papers citing papers by Ming Ta Michael Lee
This network shows the impact of papers produced by Ming Ta Michael Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Ta Michael Lee. The network helps show where Ming Ta Michael Lee may publish in the future.
Co-authorship network of co-authors of Ming Ta Michael Lee
This figure shows the co-authorship network connecting the top 25 collaborators of Ming Ta Michael Lee. A scholar is included among the top collaborators of Ming Ta Michael Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Ta Michael Lee. Ming Ta Michael Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 17 | |
| 4 | 81 | |
| 5 | 104 | |
| 6 | 14 | |
| 7 | 2 | |
| 8 | 29 | |
| 9 | 8 | |
| 10 | 30 | |
| 11 | 14 | |
| 12 | 24 | |
| 13 | 17 | |
| 14 | 80 | |
| 15 | 9 | |
| 16 | 14 |
About Ming Ta Michael Lee
Ming Ta Michael Lee is a scholar working on Pharmacology, Toxicology and Obstetrics and Gynecology, having authored 16 papers that have together received 452 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Drug-Induced Adverse Reactions (3 papers). The work is most often cited by research in Pharmacology (246 citations), Pharmacology (87 citations) and Internal Medicine (18 citations). Ming Ta Michael Lee has collaborated with scholars based in United States, Japan and Taiwan. Frequent co-authors include Teri E. Klein, Andrea Gaedigk, Michelle Whirl‐Carrillo, Jason H. Karnes, Alison E. Fohner, Rachel Huddart, Elizabeth J. Phillips, John T. Callaghan, Adrián LLerena and Christine M. Formea. Their work appears in journals such as PLoS ONE, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.